The role of novel antipsychotics in bipolar disorders

Journal of Clinical Psychiatry

Volumn 63, Issue SUPPL. 3, 2002, Pages 10-14

  Yatham, Lakshmi N ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLOZAPINE; HALOPERIDOL; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; RISPERIDONE; VALPROATE SEMISODIUM; VALPROIC ACID; ZIPRASIDONE;

AGRANULOCYTOSIS; ARTICLE; CLINICAL TRIAL; EXTRAPYRAMIDAL SYMPTOM; HUMAN; MANIA; MANIC DEPRESSIVE PSYCHOSIS; MULTICENTER STUDY; PRIORITY JOURNAL; SEIZURE; SOMNOLENCE; TARDIVE DYSKINESIA;

ACUTE DISEASE; ANTIMANIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; HALOPERIDOL; HUMANS; LITHIUM; PIRENZEPINE; RANDOMIZED CONTROLLED TRIALS; RISPERIDONE;

EID: 0036123131     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Utilization thérapeutique psychiatrique d'une phenothiazine d'action centrale élective (4560 RP)
2. Antipsychotic agents and bipolar disorder
3. Schizoaffective patients
4. Recent advances in treatment of acute mania
5. Comparison of lithium carbonate and chlorpromazine in the treatment of mania
6. Course of the manic-depressive cycle and changes caused by treatment
7. Depot antipsychotics in the prophylaxis of bipolar affective disorder
8. Tardive dyskinesia in affective disorders
9. Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients
10. Risperidone compared with both lithium and haloperidol in mania: A double-blind randomized controlled trial
11. Safety and efficacy of risperidone as combination therapy for the manic phase of bipolar disorder: Preliminary findings of a randomized, double-blind study (RIS-INT-46)
12. Safety and efficacy of risperidone versus placebo in combination with lithium or valproate in the treatment of the manic phase of the bipolar disorder
13. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: Results from a 6-month, multicenter, open study
14. Olanzapine versus placebo in the treatment of acute mania
15. Efficacy of olanzapine in acute bipolar mania: A double-blind, placebo-controlled study
16. Long-term olanzapine therapy in the treatment of bipolar I disorder: An open-label continuation phase study
17. Olanzapine compared to lithium in mania: A double-blind randomized controlled trial
18. Olanzapine versus divatproex sodium for the treatment of acute mania
19. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy
20. A 3-week double-blind, randomized trial of ziprasidone in the acute treatment of mania
21. The use of quetiapine for treatment-resistant bipolar disorder: A case series
22. Clinical predictors of acute response with quetiapine in psychotic mood disorders
23. Clozapine for treatment-refractory mania
24. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania